NEWLY DIAGNOSED MULTIPLE MYELOMA
Clinical trials for NEWLY DIAGNOSED MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail of cancer drugs aims to wipe out myeloma before transplant
Disease control Recruiting nowThis Phase 3 trial tests three different drug combinations for people with newly diagnosed multiple myeloma who are eligible for a stem cell transplant. The goal is to see which combination leads to the deepest remission (measured by minimal residual disease negativity) after 18 …
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New hope for frail myeloma patients: phase III trial tests smarter drug combos
Disease control Recruiting nowThis phase III trial is testing three different drug combinations for people newly diagnosed with multiple myeloma who are considered frail or intermediate-fit and are not getting a stem cell transplant. The study compares three-drug induction regimens followed by either double o…
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for myeloma patients: drug combo trial launches
Disease control Recruiting nowThis Phase 3 trial tests whether a new combination of drugs—belantamab mafodotin, lenalidomide, and dexamethasone—can help people with newly diagnosed multiple myeloma who cannot have a stem cell transplant. The study will compare this new combo to the current standard treatment …
Matched conditions: NEWLY DIAGNOSED MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC